Atom | Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimers Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

Due Dates (Anticipated): October 2026 (Full application deadline, projected)

Funding Amounts: Award size not yet specified; funding instrument is Cooperative Agreement (U01); duration and total program funding to be announced.

Summary: Supports preclinical validation and early-stage drug discovery for novel therapeutic targets in Alzheimer's disease and related dementias.

Key Information: This is a forecasted opportunity; application details and funding specifics will be available in the official NOFO.

Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimers Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)